Cationic phosphonolipids as nonviral vectors: In vitro and in vivo applications

Journal of Pharmaceutical Sciences

Volumn 89, Issue 5, 2000, Pages 629-638

  Delepine, P ^a   Guillaume, C ^a   Floch, V ^a   Loisel, S ^a   Yaouanc, J J ^b   Clement, J C ^b   Abbayes, H Des ^b   Ferec, C ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; LUCIFERASE; PHOSPHONIC ACID DERIVATIVE; PHOSPHONOLIPID; PLASMID DNA; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DNA TRANSFER; DRUG DESIGN; DRUG STRUCTURE; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; HUMAN; NONHUMAN; REPORTER GENE; STRUCTURE ACTIVITY RELATION;

EID: 0033821975     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6017(200005)89:5<629::AID-JPS8>3.0.CO;2-P     Document Type: Conference Paper

References (34)

1. Nonviral strategies for gene therapy
2. Gene therapy - Where are we?
3. Nomenclature for synthetic gene delivery systems
4. Gene therapy for central nervous system injury: The use of cationic liposomes: An invited review
5. Gene transfection by cationic liposomes: Comparison of the transfection efficacy of liposomes prepared from various positively charged lipids
6. Les vecteurs non viraux de therapie genique
7. Nonviral gene therapy: The promise of gene as pharmaceutical products
8. Cationic phosphonolipids as non viral vectors for DNA transfection
9. Novel cationic phosphonolipids agents for in vitro gene transfer to epithelial cell lines
10. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
11. Cationic phosphonolipids as non viral vectors for DNA transfection in hematopoietic cell lines and CD34+ cells
12. Transgene expression kinetics after transfection with cationic phosphonolipids in hematopoietic non adherent cells
13. Improved FACS-Gal: Flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs
14. Cationic phosphonolipids as nonviral gene transfer agents in the lungs of mice
15. Systemic gene therapy: Biodistribution and long-term expression of a transgene in mice
16. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
17. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery
18. Expression of the human multidrug resistance and glucocerebrosidase cDNAs from adeno-associated vectors: Efficient promoter activity of AAV sequences and in vivo delivery via liposomes
19. Influence of cholesterol on the association of plasma proteins with liposomes
20. Phosphonolipids as non-viral vectors for gene therapy
21. The counterion influence on lipid-mediated transfection of plasmid DNA
22. Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes
23. Aerosol gene delivery in vivo
24. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration
25. Systemic administration of cationic lipids/DNA complexes and the relationship between formulation and lung transfection efficiency
26. Cationic lipid-mediated gene delivery to murine lung: Correlation of lipid hydration with in vivo transfection activity
27. Liposome-mediated delivery of deoxyribonucleic acid to cells: Enhanced efficiency of delivery related to lipid composition and incubation conditions
28. Cellular and molecular barriers to gene transfer by a cationic lipid
29. Structural and functional analysis of cationic transfection lipids: The hydrophobic domain
30. Improvements in cationic liposomes for in vivo gene transfer
31. Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC
32. Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits
33. Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy